Bioengineering
-
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutations
This article has 41 authors:Reviewed by ScreenIT
-
Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells
This article has 8 authors:Reviewed by ScreenIT
-
Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamsters
This article has 18 authors:Reviewed by ScreenIT
-
In vitro characterization of engineered red blood cells as potent viral traps against HIV-1 and SARS-CoV-2
This article has 3 authors:Reviewed by ScreenIT
-
EXPERIMENTAL INVESTIGATION OF PULSE STERILIZATION OF VIRAL INFECTION
This article has 7 authors:Reviewed by ScreenIT
-
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2
This article has 11 authors:Reviewed by ScreenIT
-
CAR Macrophages for SARS-CoV-2 Immunotherapy
This article has 7 authors:Reviewed by ScreenIT
-
Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2
This article has 4 authors:Reviewed by ScreenIT
-
De Novo Discovery of High Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
This article has 9 authors:Reviewed by ScreenIT